FSD Pharma Inc.

HUGE · NASDAQ
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Assets
Cash & Equivalents$2,757$16,980$35,260$17,525
Short-Term Investments$752$23$158$0
Receivables$7,379$374$501$161
Inventory$0$0$14$0
Other Curr. Assets$155$472$10,014$9,180
Total Curr. Assets$11,085$17,850$45,933$26,866
Property Plant & Equip (Net)$120$261$168$0
Goodwill$0$0$0$0
Intangibles$5,356$12,040$16,202$13,424
Long-Term Investments$6$828$660$1,677
Tax Assets$0$0$22$0
Other NC Assets$0$7,432-$22-$0
Total NC Assets$6,390$20,560$17,030$15,101
Other Assets$0$0$0$0
Total Assets$17,475$38,411$62,963$41,967
Liabilities
Payables$3,241$2,760$2,996$2,063
Short-Term Debt$339$478$425$431
Tax Payable$0$0$0$0
Deferred Revenue$0$0$4,515$0
Other Curr. Liab.$986$4,592$5,280$3,085
Total Curr. Liab.$4,542$7,830$8,701$5,580
LT Debt$0$38$131$79
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$0$38$131$79
Other Liabilities$0$0$0$0
Cap. Leases$39$216$255$126
Total Liabilities$4,566$7,868$8,832$5,659
Equity
Pref Stock$0$0$0$0
Common Stock$137,074$143,411$152,325$103,208
Retained Earnings-$157,908-$144,164-$126,154-$90,869
AOCI$417$653$240$208
Other Equity$32,949$30,643$27,721$23,762
Total Equity$13,169$30,542$54,131$36,309
Supplemental Information
Minority Interest-$434$0$0$0
Total Liab. & Tot. Equity$17,475$38,411$62,963$41,967
Net Debt-$2,418-$16,464-$34,704-$17,014